Kingsman; Susan Mary
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kingsman; Susan Mary.The latest application filed is for "chemo-immunotherapy method".
Company Profile
0.19.36
- Kingsman; Susan Mary - Oxon GB
- Kingsman; Susan Mary - Oxford GB
- Kingsman; Susan Mary - Appleton GB
- Kingsman; Susan Mary - Islip GB
- Kingsman, Susan Mary - The Oxford Science Park GB
Patent Activity
| Patent | Date |
|---|---|
| Chemo-immunotherapy Method App 20120213822 - Harrop; Richard ; et al. | 2012-08-23 |
| Peptide Grant 8,147,838 - Harrop , et al. April 3, 2 | 2012-04-03 |
| Chemo-immunotherapy method Grant 8,133,681 - Harrop , et al. March 13, 2 | 2012-03-13 |
| Vector Grant 8,084,249 - Kingsman , et al. December 27, 2 | 2011-12-27 |
| Vector App 20110065173 - Kingsman; Susan Mary ; et al. | 2011-03-17 |
| Antibodies App 20110052577 - Kingsman; Alan ; et al. | 2011-03-03 |
| MHC class I peptide epitopes from the human 5T4 tumor-associated antigen Grant 7,888,115 - Carroll , et al. February 15, 2 | 2011-02-15 |
| Cascade App 20100158884 - Harrop; Richard ; et al. | 2010-06-24 |
| Vector System App 20100040539 - Kingsman; Alan ; et al. | 2010-02-18 |
| Vector system Grant 7,635,687 - Kingsman , et al. December 22, 2 | 2009-12-22 |
| Retroviral vectors App 20090291491 - Kingsman; Alan John ; et al. | 2009-11-26 |
| Vector encoding an antibody that binds 5T4 antigen Grant 7,531,648 - Kingsman , et al. May 12, 2 | 2009-05-12 |
| Vector System App 20090111106 - Mitrophanous; Kyri ; et al. | 2009-04-30 |
| Antibodies Grant 7,514,546 - Kingsman , et al. April 7, 2 | 2009-04-07 |
| Chemo-Immunotherapy Method App 20090047307 - Harrop; Richard ; et al. | 2009-02-19 |
| Vector App 20090017532 - Kingsman; Susan Mary ; et al. | 2009-01-15 |
| Vector system App 20080131400 - Mazarakis; Nicholas ; et al. | 2008-06-05 |
| Anemia App 20080125387 - Binley; Katie Mary ; et al. | 2008-05-29 |
| Lentiviral LTR-deleted vector App 20080064106 - Kingsman; Alan John ; et al. | 2008-03-13 |
| Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site Grant 7,303,910 - Bebbington , et al. December 4, 2 | 2007-12-04 |
| Antibodies App 20070259400 - Kingsman; Alan ; et al. | 2007-11-08 |
| Antibodies App 20070161080 - Kingsman; Alan ; et al. | 2007-07-12 |
| Retroviral vectors App 20070104690 - Kingsman; Alan John ; et al. | 2007-05-10 |
| Retroviral vectors Grant 7,198,784 - Kingsman , et al. April 3, 2 | 2007-04-03 |
| Vector App 20060286634 - Kingsman; Susan Mary ; et al. | 2006-12-21 |
| Lentiviral LTR-deleted vector App 20060177934 - Kingsman; Alan John ; et al. | 2006-08-10 |
| Antibodies Grant 7,074,909 - Kingsman , et al. July 11, 2 | 2006-07-11 |
| Lentiviral LTR-deleted vector Grant 7,056,699 - Kingsman , et al. June 6, 2 | 2006-06-06 |
| Retroviral vectors App 20060024279 - Kingsman; Susan Mary ; et al. | 2006-02-02 |
| Antibodies App 20060014222 - Kingsman; Susan Mary ; et al. | 2006-01-19 |
| Lentiviral LTR-deleted vector App 20050238629 - Kingsman, Alan John ; et al. | 2005-10-27 |
| Lentiviral LTR-deleted vector Grant 6,924,123 - Kingsman , et al. August 2, 2 | 2005-08-02 |
| Anemia App 20050124564 - Binley, Katie Mary ; et al. | 2005-06-09 |
| Vector App 20050032216 - Kingsman, Susan Mary ; et al. | 2005-02-10 |
| Tumor targeted vector Grant 6,852,703 - Kingsman , et al. February 8, 2 | 2005-02-08 |
| Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site App 20050009186 - Bebbington, Christopher Robert ; et al. | 2005-01-13 |
| Polynucleotide constructs and uses thereof App 20040234505 - Naylor, Stuart ; et al. | 2004-11-25 |
| Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site Grant 6,808,922 - Bebbington , et al. October 26, 2 | 2004-10-26 |
| Lentiviral-mediated growth factor gene therapy for nerodegenerative diseases App 20040202642 - Arbischer, Patrick ; et al. | 2004-10-14 |
| Lentiviral-mediated growth factor gene therapy for neurodegenerative diseases Grant 6,800,281 - Aebischer , et al. October 5, 2 | 2004-10-05 |
| Vector system App 20040131591 - Kingsman, Alan John ; et al. | 2004-07-08 |
| Retroviral vectors App 20040086488 - Kingsman, Alan John ; et al. | 2004-05-06 |
| Vector system App 20040076613 - Mazarakis, Nicholas ; et al. | 2004-04-22 |
| Retroviral vectors Grant 6,669,936 - Kingsman , et al. December 30, 2 | 2003-12-30 |
| Analysis method App 20030203372 - Ward, Neil Raymond ; et al. | 2003-10-30 |
| Anemia App 20030143202 - Binley, Katie (Mary) ; et al. | 2003-07-31 |
| Lentiviral LTR-deleted vector App 20030113920 - Kingsman, Alan John ; et al. | 2003-06-19 |
| Vector App 20030018004 - Kingsman, Susan Mary ; et al. | 2003-01-23 |
| Lentiviral-mediated growth factor gene therapy for neurodegenerative diseases App 20020187951 - Aebischer, Patrick ; et al. | 2002-12-12 |
| Retroviral Vectors App 20020141978 - KINGSMAN, SUSAN MARY ; et al. | 2002-10-03 |
| Vector App 20020034393 - Mitrophanous, Kyriacos A. ; et al. | 2002-03-21 |
| Retroviral vectors App 20020034502 - Kingsman, Alan John ; et al. | 2002-03-21 |
| Retroviral vectors Grant 6,312,682 - Kingsman , et al. November 6, 2 | 2001-11-06 |
| Lentiviral vectors Grant 6,235,522 - Kingsman , et al. May 22, 2 | 2001-05-22 |
| Hybrid GAL10/pgk yeast promoter Grant 5,739,007 - Kingsman , et al. April 14, 1 | 1998-04-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 